Treatment of chronic graft-versus-host disease with bortezomib

Post-Transplantation B Cell Activating Factor and B Cell Recovery before Onset of Chronic Graft-versus-Host Disease

(2014) Caron A. Jacobson et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans

(2014) R. Flynn et al.   BLOOD

CD19+CD21low B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome

(2013) Z. Kuzmina et al.   BLOOD

Proteasome Inhibition Profoundly Affects Activated Human B Cells

(2013) Arend Mulder et al.   TRANSPLANTATION

Proteasome inhibitors in multiple myeloma: 10 years later

(2012) P. Moreau et al.   BLOOD

B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways

(2012) J. L. Allen et al.   BLOOD

Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation

(2012) John Koreth et al.   JOURNAL OF CLINICAL ONCOLOGY

Donor B Cells in Transplants Augment Clonal Expansion and Survival of Pathogenic CD4+ T Cells That Mediate Autoimmune-like Chronic Graft-versus-Host Disease

(2012) J. S. Young et al.   JOURNAL OF IMMUNOLOGY

Proteasome Inhibitors as Immunosuppressants: Biological Rationale and Clinical Experience

(2012) Eva Moran et al.   SEMINARS IN HEMATOLOGY

Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans

(2011) M. Srinivasan et al.   BLOOD

Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation

(2011) John R. Wingard et al.   JOURNAL OF CLINICAL ONCOLOGY

Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis

(2011) A. M. Gomez et al.   JOURNAL OF IMMUNOLOGY

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease

(2010) Daniel Wolff et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma

(2010) G. R. Hill et al.   BLOOD

Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease

(2009) X. Chen et al.   BLOOD

Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation

(2008) K. Sun et al.   BLOOD

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

(2008) Kirsten Neubert et al.   NATURE MEDICINE